新型单分支主动脉覆膜支架治疗B型主动脉夹层的结局
本研究为前瞻性非随机单臂临床试验,纳入132例B型主动脉夹层患者,使用单分支装置保留左锁骨下动脉行胸主动脉腔内修复。30天死亡6例(4.5%),30天卒中2例(1.5%),1年无卒中率96.8%,装置技术成功129例(97.7%),手术成功110例(83.3%),1年安全性和有效性可接受。
要点
- 30天死亡6例(4.5%),30天卒中2例(1.5%),1年无卒中率96.8%。
- 装置技术成功129/132(97.7%),手术成功110/132(83.3%)。
- 1例分支通畅性丧失,未见持续性顺行假腔血流。
核心结论
- 在B型夹层TEVAR中应用单分支装置保留左锁骨下动脉,1年安全性和有效性可接受。
研究设计与样本
- 前瞻性非随机单臂临床试验,纳入132例适合分支支架置入的B型主动脉夹层患者。
主要发现
- 132例中急性B型夹层25例(18.9%),慢性B型夹层79例(59.8%),既往A型开放修复后残余夹层28例(21.1%)。
- 经皮入路105例(79.5%)。
- 30天死亡6例(4.5%)。
- 30天卒中2/132(1.5%),1年无卒中率96.8%。
- 装置技术成功129/132(97.7%),手术成功110/132(83.3%),分支通畅性丧失1例,未见持续性顺行假腔血流。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intervention on type B dissection frequently requires landing the proximal edge of the stent graft between the left common carotid artery and left subclavian artery (LSA). The GORE TAG thoracic branch endoprosthesis is a technology that allows LSA preservation with a single internal branch. METHODS: This study was a prospective nonrandomized single-arm clinical trial of patients with type B aortic dissection who were treated with the single-branched device. Patients with operative indications for acute, chronic, or residual type B dissections that originated distal to the origin of an LSA suitable for branch graft placement were eligible for the study. Native aortic and surgical graft proximal landing zones were eligible. RESULTS: Of the 132 patients, there were 25 (18.9%) acute type B dissections, 79 (59.8%) chronic type B dissections, and 28 (21.1%) residual dissections after previous open type A repair. Percutaneous access was used in 105 (79.5%) patients. Overall, 30-day mortality occurred in 6 patients (4.5%). The overall 30-day stroke rate was 2 of 132 (1.5%), and the 1-year freedom from stroke was 96.8%. Device technical success and procedural success were achieved in 129 of 132 (97.7%) and 110 of 132 (83.3%) patients, respectively, and there was 1 instance of loss of side branch patency. No persistent antegrade false lumen flow was observed. CONCLUSIONS: In this study of a novel branched endograft device to preserve the LSA in patients with type B dissection undergoing thoracic endovascular aortic repair, we demonstrate acceptable safety and efficacy outcomes at 1 year.
引用
- Desai ND, Wang GJ, Brinkman W, et al. Outcomes of a Novel Single-Branched Aortic Stent Graft for Treatment of Type B Aortic Dissection. Ann Thorac Surg. 2024. PMID: 39277156. doi:10.1016/j.athoracsur.2024.07.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。